Alzheimer Disease Clinical Trials in Lille
6 recruitingLille, France
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled140 locationsNCT07011745
Recruiting
Phase 1
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Alzheimer DiseaseMild Cognitive Impairment
Novartis Pharmaceuticals36 enrolled10 locationsNCT05469360
Recruiting
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Alzheimer DiseaseFrontotemporal Dementia
University Hospital, Lille102 enrolled1 locationNCT05288842
Recruiting
Phase 3
Effect of CAFfeine on Cognition in Alzheimer's Disease
Alzheimer Disease
University Hospital, Lille248 enrolled17 locationsNCT04570085
Recruiting
Not Applicable
Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
Alzheimer Disease
Centre Hospitalier St Anne90 enrolled3 locationsNCT05911178